Table 3. Comparison of clinical parameters between rebleed and no rebleed groups.

Characteristic	All patients (n=480)	Rebleed group (n=14)	Non Rebleed group (n=466)	P-value
Hematemesis	54(11.3%)	2(14.3%)	52(11.2%)	0.08
Malena	341(71%)	7(50%)	334(71.7%)	0.72
Hematemesis +Malena	85 (17.7%)	5(35.7%)	80(17.1%)	0.07
Hematochezia	4(0.83%)	1(7.1%)	3(0.6%)	0.11
Syncope	5(1.04%)	0(0%)	5(1.1%)	0.86
Pulse (mean ±SD)	93.5±10.8	100.4±14	93.3±10.6	0.015
Shock	83(17.3%)	7 (50%)	76(16.3%)	0.001
Hb. (mean ±SD)	9.2±2.4	8.1±2.3	9.2±2.4	0.09
HCT. (mean ±SD)	28.5±7.1	26±6.6	28.5±7.1	0.17
Creatinine  (mean±SD)	1.06±0.33	1.24±0.72	1.06±0.31	0.041
Units of blood Transfused.         (mean ±SD)	2.1±0.96	3±1..8	2.07±0.86	0.005
Pulse < 100 BP≥ 100	308 (64.2%)	5 (35.7%)	303 (65%)	0.004
Pulse ≥ 100/ BP ≥100	89 (18.5%)	2 (14.3%)	87 (18.7%)
Pulse ≥100 /BP<100	83 (17.3%)	7 (50%)	76 (16.3%)